This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Wonseon Choi
Introduction
Wonseon Choi is an accomplished inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of dermatology through his innovative research and patents. His work focuses on the modulation of skin pigmentation, which has important implications for both medical and cosmetic applications.
Latest Patents
Wonseon Choi holds a patent titled "Regulation of skin pigmentation by neuregulin-1 (NRG-1)." This patent discloses compositions and methods for modulating the pigmentation and proliferation of melanocytes. The methods can be utilized to prevent or treat skin disorders, including skin cancer, or for cosmetic purposes. One method involves contacting a melanocyte with an agent that modulates NRG-1 activity, which can either increase or decrease pigmentation. This innovation is particularly valuable for reducing UV skin damage and treating skin pigmentation disorders.
Career Highlights
Choi is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has garnered attention for its potential to improve skin health and address various skin conditions.
Collaborations
Some of his notable coworkers include Vincent J Hearing and Ludger Kolbe. Their collaborative efforts contribute to the advancement of research in skin pigmentation and related fields.
Conclusion
Wonseon Choi's innovative work in skin pigmentation regulation showcases the intersection of science and health. His contributions have the potential to make a significant impact on dermatological treatments and cosmetic applications.